Literature DB >> 12089259

Minimizing the workup of blood culture contaminants: implementation and evaluation of a laboratory-based algorithm.

S S Richter1, S E Beekmann, J L Croco, D J Diekema, F P Koontz, M A Pfaller, G V Doern.   

Abstract

An algorithm was implemented in the clinical microbiology laboratory to assess the clinical significance of organisms that are often considered contaminants (coagulase-negative staphylococci, aerobic and anaerobic diphtheroids, Micrococcus spp., Bacillus spp., and viridans group streptococci) when isolated from blood cultures. From 25 August 1999 through 30 April 2000, 12,374 blood cultures were submitted to the University of Iowa Clinical Microbiology Laboratory. Potential contaminants were recovered from 495 of 1,040 positive blood cultures. If one or more additional blood cultures were obtained within +/-48 h and all were negative, the isolate was considered a contaminant. Antimicrobial susceptibility testing (AST) of these probable contaminants was not performed unless requested. If no additional blood cultures were submitted or there were additional positive blood cultures (within +/-48 h), a pathology resident gathered patient clinical information and made a judgment regarding the isolate's significance. To evaluate the accuracy of these algorithm-based assignments, a nurse epidemiologist in approximately 60% of the cases performed a retrospective chart review. Agreement between the findings of the retrospective chart review and the automatic classification of the isolates with additional negative blood cultures as probable contaminants occurred among 85.8% of 225 isolates. In response to physician requests, AST had been performed on 15 of the 32 isolates with additional negative cultures considered significant by retrospective chart review. Agreement of pathology resident assignment with the retrospective chart review occurred among 74.6% of 71 isolates. The laboratory-based algorithm provided an acceptably accurate means for assessing the clinical significance of potential contaminants recovered from blood cultures.

Entities:  

Mesh:

Year:  2002        PMID: 12089259      PMCID: PMC120579          DOI: 10.1128/JCM.40.7.2437-2444.2002

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  15 in total

1.  Nosocomial bloodstream infections: are positive blood cultures misleading?

Authors:  Y Siegman-Igra; C Ernst
Journal:  Clin Infect Dis       Date:  2000-06       Impact factor: 9.079

2.  Relevance of the number of positive bottles in determining clinical significance of coagulase-negative staphylococci in blood cultures.

Authors:  S Mirrett; M P Weinstein; L G Reimer; M L Wilson; L B Reller
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

3.  Contaminant blood cultures and resource utilization. The true consequences of false-positive results.

Authors:  D W Bates; L Goldman; T H Lee
Journal:  JAMA       Date:  1991-01-16       Impact factor: 56.272

4.  Evaluation of positive blood cultures. Guidelines for early differentiation of contaminated from valid positive cultures.

Authors:  R R MacGregor; H N Beaty
Journal:  Arch Intern Med       Date:  1972-07

5.  Epidemiology and clinical significance of blood cultures positive for coagulase-negative staphylococcus.

Authors:  L V Kirchhoff; J N Sheagren
Journal:  Infect Control       Date:  1985-12

6.  Coagulase-negative staphylococci in blood cultures: the clinician's dilemma.

Authors:  G L Archer
Journal:  Infect Control       Date:  1985-12

7.  Pseudobacteremia.

Authors:  J F John; E R Bannister
Journal:  Infect Control       Date:  1984-02

8.  Hospital-acquired bloodstream infections with Staphylococcus epidermidis. Review of 100 cases.

Authors:  S Ponce de Leon; R P Wenzel
Journal:  Am J Med       Date:  1984-10       Impact factor: 4.965

9.  Early evaluation of coagulase negative staphylococcus in blood samples of intensive care unit patients. A clinically uncertain judgement.

Authors:  E Dominguez-de Villota; A Algora-Weber; I Millán; J J Rubio; P Galdos; J M Mosquera
Journal:  Intensive Care Med       Date:  1987       Impact factor: 17.440

10.  Blood cultures positive for coagulase-negative staphylococci: antisepsis, pseudobacteremia, and therapy of patients.

Authors:  D Souvenir; D E Anderson; S Palpant; H Mroch; S Askin; J Anderson; J Claridge; J Eiland; C Malone; M W Garrison; P Watson; D M Campbell
Journal:  J Clin Microbiol       Date:  1998-07       Impact factor: 5.948

View more
  52 in total

1.  Direct susceptibility testing of positive blood cultures by using Sensititre broth microdilution plates.

Authors:  Kimberle C Chapin; Michael C Musgnug
Journal:  J Clin Microbiol       Date:  2003-10       Impact factor: 5.948

2.  Multiplex PCR for rapid and improved diagnosis of bloodstream infections in liver transplant recipients.

Authors:  Peter-Michael Rath; Fuat Saner; Andreas Paul; Nils Lehmann; Eike Steinmann; Jan Buer; Joerg Steinmann
Journal:  J Clin Microbiol       Date:  2012-04-04       Impact factor: 5.948

Review 3.  Blood culture contamination: persisting problems and partial progress.

Authors:  Melvin P Weinstein
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

4.  Performance of the Verigene Gram-positive blood culture assay for direct detection of Gram-positive organisms and resistance markers in a pediatric hospital.

Authors:  Javier Mestas; Claudia M Polanco; Susanna Felsenstein; Jennifer Dien Bard
Journal:  J Clin Microbiol       Date:  2013-10-16       Impact factor: 5.948

5.  Monitoring of patients supported by extracorporeal membrane oxygenation for systemic infections by broad-range rRNA gene PCR amplification and sequence analysis.

Authors:  Peter Orszag; Claudia Disqué; Sonja Keim; Michael G Lorenz; Olaf Wiesner; Johannes Hadem; Meike Stiesch; Axel Haverich; Christian Kühn
Journal:  J Clin Microbiol       Date:  2013-10-23       Impact factor: 5.948

6.  Positive Predictive Value of True Bacteremia according to the Number of Positive Culture Sets in Adult Patients.

Authors:  Tsuyoshi Kitaura; Hiroki Chikumi; Hiromitsu Fujiwara; Kensaku Okada; Tatsuya Hayabuchi; Masaki Nakamoto; Miyako Takata; Akira Yamasaki; Tadashi Igishi; Naoto Burioka; Eiji Shimizu
Journal:  Yonago Acta Med       Date:  2014-12-26       Impact factor: 1.641

7.  High medical impact of implementing the new polymeric bead-based BacT/ALERT® FAPlus and FNPlus blood culture bottles in standard care.

Authors:  R Amarsy-Guerle; F Mougari; H Jacquier; J Oliary; H Benmansour; J Riahi; B Berçot; L Raskine; E Cambau
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-02-04       Impact factor: 3.267

8.  Blood cultures at central line insertion in the intensive care unit: comparison with peripheral venipuncture.

Authors:  Sheldon Stohl; Shmuel Benenson; Sigal Sviri; Alexander Avidan; Colin Block; Charles L Sprung; Phillip D Levin
Journal:  J Clin Microbiol       Date:  2011-04-27       Impact factor: 5.948

9.  Evaluation of quantitative antibiotic susceptibility testing by Vitek 2 as a routine method to predict strain relatedness of coagulase-negative staphylococci isolated from blood cultures.

Authors:  Antonia Camerer; Anke Kohlenberg; Danuta Stefanik; Harald Seifert
Journal:  J Clin Microbiol       Date:  2011-07-27       Impact factor: 5.948

10.  Risk prediction with procalcitonin and clinical rules in community-acquired pneumonia.

Authors:  David T Huang; Lisa A Weissfeld; John A Kellum; Donald M Yealy; Lan Kong; Michael Martino; Derek C Angus
Journal:  Ann Emerg Med       Date:  2008-03-17       Impact factor: 5.721

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.